(Q39346170)

11 September 2017

title

Specificity of cell-mediated cytotoxicity against human melanoma lines: evidence for "non-specific" killing by activated T-cells (English)

2 references

11 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A51832

8 April 2022

Specificity of cell-mediated cytotoxicity against human melanoma lines: Evidence for “non-specific” killing by activated T-cells (English)

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

immunologic cytotoxicity tests

8 April 2022

main subject

cytotoxicity

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A51832

8 April 2022

lymphocyte activation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A51832

8 April 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

8 April 2022

author name string

P. Hersey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A51832

8 April 2022

A. Edwards

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A51832

8 April 2022

J. Edwards

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A51832

8 April 2022

E. Adams

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A51832

8 April 2022

G. W. Milton

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A51832

8 April 2022

D. S. Nelson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A51832

8 April 2022

language of work or name

English

0 references

publication date

1 July 1975

1 reference

11 September 2017

15 July 1975

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=51832

full work available at URL

8 April 2022

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910160119

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.2910160119

8 April 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

International Journal of Cancer

8 April 2022

published in

1 reference

11 September 2017

volume

16

1 reference

11 September 2017

issue

1

1 reference

11 September 2017

page(s)

173-183

1 reference

Cell mediated immunity: separation of cells involved in recognitive and destructive phases

11 September 2017

cites work

1

180

403

Bach

1973

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization

8 April 2022

2

132

702

Bianco

1970

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

The glomerular permeability determined by dextran clearance using Sephadex gel filtration

8 April 2022

3

21

77

Boyüm

1968

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

Nonspecific cytotoxic effects of antigen-transformed lymphocytes. Kinetics, cell-requirements and the role of recruitment

8 April 2022

Immunization with Irradiated Tumour Cells and Specific Lymphocyte Cytotoxicity in Malignant Melanoma

4

volume

7

page(s)

357

0 references

5

2

305

Currie

1971

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

Cytotoxic lymphocytes in melanoma patients

8 April 2022

7

9

567

De Vries

1972

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

Mechanism of Immunologically Specific Killing of Tumour Cells by Macrophages

8 April 2022

8

236

168

Evans

1972

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

Cellular and humoral immunity against human malignant melanoma

8 April 2022

9

8

344

Fossati

1971

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma

8 April 2022

10

11

280

Hellström

1973

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

Thymus-dependent cytotoxic lymphocytes in the rat

8 April 2022

11

3

748

Hersey

1973

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

Comparison of 51Cr release and microcytotoxicity assays against human melanoma cells

8 April 2022

14

16

164

Hersey

1975

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

Possible role of macrophage mediated nonspecific cytotoxicity in tumour resistance

8 April 2022

15

235

48

Hibbs

1972

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

Control of Carcinogenesis: A Possible Role for the Activated Macrophage

8 April 2022

16

177

998

Hibbs

1972

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

Cytotoxic potential of stimulated human lymphocytes

8 April 2022

17

125

721

Holm

1967

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

Natural antibody in human serum to a neoantigen in human cultured cells grown in fetal bovine serum.

8 April 2022

18

52

1051

Irie

1974

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

Specificity of cellular immune reactivity to virus-induced tumours.

8 April 2022

22

238

18

Ortiz-Landazuri

1972

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy.

8 April 2022

23

10

77

O'toole

0 references

Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells?

24

1

1085

O'Toole

1973

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker

8 April 2022

25

139

457

O'Toole

1974

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

Destruction of human lymphoid tissue-culture cell lines by human peripheral lymphocytes in 51Cr-release cellular cytotoxicity assays

8 April 2022

29

52

345

Rosenberg

1974

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

Differential cytotoxicity of activated lymphocytes on allogeneic and xenogeneic target cells. I. Activation by tuberculin and by Staphylococcus filtrate

8 April 2022

31

8

71

Stejskal

1973

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

Sensitivity of different target cells to the killing action of peripheral lymphocytes stimulated by autologous lymphoblastoid cell lines

8 April 2022

32

13

891

Svedmyr

1974

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

8 April 2022

33

33

2898

Takasugi

1973

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160119

8 April 2022

Identifiers

1 reference

11 September 2017

1 reference